Lisata Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Lisata Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Lisata Therapeutics Inc Strategy Report
- Understand Lisata Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Lisata Therapeutics Inc (Lisata Therapeutics), formerly Caladrius Biosciences Inc, is a biopharmaceutical company. It discovers and develops cellular therapies for the treatment of cardiovascular indications and autoimmune diseases. It is investigating XOWNA for the treatment of coronary microvascular dysfunction; HONEDRA against critical limb ischemia and buerger’s disease. The company is also evaluating CLBS201 for the treatment of diabetic kidney disease (DKD); and CLBS14 to treat no-option refractory disabling angina. Lisata Therapeutics utilizes its proprietary CD34+ cell therapy technology to develop therapies for ischemia diseases. It serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. Lisata Therapeutics is headquartered in Basking Ridge, New Jersey, the US.
Lisata Therapeutics Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Pipeline | XOWNA |
XOWNA: | HONEDRA |
Coronary Microvascular Dysfunction | |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Lisata Therapeutics Inc | Acorda Therapeutics Inc | Provention Bio Inc | Capricor Therapeutics Inc | BrainStorm Cell Therapeutics Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Basking Ridge | Pearl River | Red Bank | Beverly Hills | New York |
State/Province | New Jersey | New York | New Jersey | California | New York |
No. of Employees | 25 | 111 | 174 | 74 | 43 |
Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Gregory B. Brown | Chairman | Executive Board | 2017 | 69 |
David J. Mazzo Phd | Chief Executive Officer; Director; President | Executive Board | 2017 | 66 |
Gregory S. Berkin | Chief Information Officer | Senior Management | - | - |
Kristen K. Buck | Chief Medical Officer; Executive Vice President - Research and Development | Senior Management | - | 49 |
Gail Holler | Vice President - Human Resources | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward